Back to top
more

Masimo (MASI)

(Real Time Quote from BATS)

$163.89 USD

163.89
129,375

+3.04 (1.89%)

Updated Nov 13, 2024 01:34 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 26% (65 out of 250)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Abbott's Troponin-I Wins CE Mark, Vascular Arm Gets a Revamp

by Zacks Equity Research

Abbott's (ABT) life-changing High Sensitive Troponin-I test uses a biomarker, specific to the heart.

    Cerner CommunityWorks Selected by Pershing Health System

    by Zacks Equity Research

    Cerner (CERN) witnesses consistent growth in the Electronic Health Record platform and Revenue Cycle Management solutions.

      Hologic's Focal Therapeutics Buyout to Boost Breast Health Arm

      by Zacks Equity Research

      Hologic (HOLX) progresses with initiatives to boost the Breast Health unit. The recent buyout is likely to widen portfolio and fortify Hologic's position in the breast conserving surgery market.

        Here's Why You Should Add Edwards Lifesciences Right Away

        by Zacks Equity Research

        We are upbeat about the continued strength in Edwards Lifesciences' (EW) THVT business.

          Baxter's (BAX) ALTAPORE Bioactive Bone Graft Gets FDA Nod

          by Zacks Equity Research

          Baxter's (BAX) offers a broad spectrum of surgical products, including bone grafts and substitutes that see lucrative market prospects.

            Will LabCorp's (LH) Food Solution Divestment Upset Sales?

            by Zacks Equity Research

            LabCorp's (LH) lackluster outlook for 2018 includes the earlier-announced divestment of its Food Solutions business.

              Neogen (NEOG) Earnings Beat, Revenues Lag Estimates in Q1

              by Zacks Equity Research

              Accretive integrations and an expanding international footprint drive Neogen's (NEOG) earnings in Q1.

                Here's Why You Should Buy Baxter International (BAX) Now

                by Zacks Equity Research

                Baxter's (BAX) raised guidance for 2018 and a series of approvals make it a promising investment pick.

                  RTI Surgical's (RTIX) TETRAfuse Wins Spine Technology Award

                  by Zacks Equity Research

                  RTI Surgical (RTIX) to receive the Spine Technology Award from Orthopedics This Week at the NASS 33rd Annual Meeting in Los Angeles.

                    Boston Scientific Thrives in Urology on New LithoVue Empower

                    by Zacks Equity Research

                    Boston Scientific's (BSX) combination of LithoVue Empower and LithoVue Single-Use Digital Ureteroscope will put the whole stone manipulation procedure in the operating surgeon's hands.

                      Quest Diagnostics Grows in Fertility Services With New Buyout

                      by Zacks Equity Research

                      Quest Diagnostics' (DGX) acquisition of ReproSource lies in tandem with the company's accelerated growth strategy, especially in advanced diagnostics.

                        Abiomed's Impella Ensures Higher Survival Rates, Shares Up

                        by Zacks Equity Research

                        Abiomed's (ABMD) Impella successfully treats patients with cardiogenic shocks; market prospects bright.

                          Here's Why You Should Invest in Walgreens Boots Stock Now

                          by Zacks Equity Research

                          Walgreens Boots (WBA) gains from tie-ups. The company's alliance with Express Scripts encourages.

                            Boston Scientific's FDA Nod for Eluvia Stent Expands PI Suite

                            by Zacks Equity Research

                            Boston Scientific's (BSX) PMA approval for Eluvia Drug-Eluting Vascular Stent System will help boost the top line at the PI business.

                              Here's Why You Should Invest in PRA Health (PRAH) Stock Now

                              by Zacks Equity Research

                              The CRO industry's bullish prospects currently make PRA Health (PRAH) a promising investment pick.

                                Intuitive Surgical and InTouch Collaborate for IoMT Services

                                by Zacks Equity Research

                                Intuitive Surgical's (ISRG) IoMT likely to benefit patients; market prospects impressive.

                                  TransEnterix's MST Medical Buyout to Boost Senhance Platform

                                  by Zacks Equity Research

                                  TransEnterix (TRXC) acquires Israel-based MST Medical, which will boost surgeons' effectiveness and make procedures quick and error-free.

                                    Medical Instruments Stock Outlook: Long-Term Prospects Bright

                                    by Zacks Equity Research

                                    Research and development in the medical instruments industry is on the rise. FDA's approval of gene therapy for inherited renal disease and Big Data for healthcare set to revolutionize the field.

                                    Here's Why You Should Buy Intuitive Surgical (ISRG) Now

                                    by Zacks Equity Research

                                    Strength in the surgical platform and a string of developments make Intuitive Surgical (ISRG) a promising pick.

                                      Medtronic to Buy Mazor Robotics for Robotic Spine Surgery

                                      by Zacks Equity Research

                                      The consolidation will combine Medtronic's (MDT) spine implants, navigation and intra-operative imaging technology with Mazor Robotics' robotic-assisted surgery (RAS) systems.

                                        Sweta Jaiswal headshot

                                        3 MedTech Stocks for Safe Returns as Hurricane Fears Peak

                                        by Sweta Jaiswal

                                        With the hurricane season at the peak, we bring three safe picks for investors.

                                          Cerner's CommunityWorks Picked by Reeves County Hospital

                                          by Zacks Equity Research

                                          Cerner (CERN) sees a slew of developments in its EHR platform, market prospects bright.

                                            Cardiovascular Systems Stealth 360 Peripheral OAS Goes Global

                                            by Zacks Equity Research

                                            Following the recent extension of its partnership with OrbusNeich, Cardiovascular Systems' (CSII) Stealth 360 Peripheral OAS is put to first commercial use in Hong Kong.

                                              Insulet Advances on Omnipod Reimbursement Update, Runs Risks

                                              by Zacks Equity Research

                                              Insulet (PODD) commences 2018 with favorable reimbursement updates. The company attains several landmarks regarding Omnipod's market reach.

                                                Here's Why You Should Hold on to Align Technology (ALGN) Now

                                                by Zacks Equity Research

                                                Continued strength in Align Technology's (ALGN) Invisalign volumes impresses. Overdependence on Invisalign Technology system is a concern.